Related Experiment Videos
Facial swelling in giant cell (temporal) arteritis
F D Ghanchi1, C Weir, J Dudgeon
1Tennent Institute of Ophthalmology, Glasgow, UK.
Eye (London, England)
|January 1, 1996
Summary
Facial swelling can be a rare sign of giant cell arteritis, potentially leading to vision loss. Prompt steroid treatment for this condition and associated arteritic anterior ischaemic optic neuropathy (AION) can preserve sight.
Area of Science:
- Rheumatology
- Ophthalmology
- Vascular Medicine
Background:
- Giant cell arteritis (GCA) is a systemic vasculitis primarily affecting the elderly.
- Facial swelling is an uncommon but significant manifestation of GCA.
- Delayed diagnosis of GCA can lead to irreversible vision loss, particularly anterior ischaemic optic neuropathy (AION).
Observation:
- A case report of a biopsy-proven GCA patient presenting with facial swelling.
- The patient subsequently developed anterior ischaemic optic neuropathy (AION), a serious complication.
- Facial swelling preceded the onset of AION in this patient.
Findings:
- Both facial swelling and arteritic AION demonstrated a positive response to high-dose corticosteroid therapy.
- The study highlights a potential correlation between facial swelling and the risk of developing AION in GCA patients.
- Prompt treatment with intravenous steroids was effective in preserving vision.
Implications:
- Facial swelling in the context of GCA should be recognized as a potential warning sign for impending AION.
- Aggressive steroid treatment, particularly intravenous administration, may be vital for salvaging vision in such cases.
- This finding underscores the importance of vigilant monitoring for ocular complications in GCA patients presenting with atypical symptoms like facial swelling.